tiprankstipranks
Xeris Pharmaceuticals (DE:2B30)
FRANKFURT:2B30
Germany Market
Holding DE:2B30?
Track your performance easily

Xeris Pharmaceuticals (2B30) Income Statement

0 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q3 2024), Xeris Pharmaceuticals's total revenue was $54.27M, a decrease of ― from the same quarter last year. In Q3, Xeris Pharmaceuticals's net income was $-15.74M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Jun 23Mar 23Dec 22Dec 21
Total Revenue
$ 191.29M$ 163.91M$ 38.01M$ 33.20M$ 110.25M$ 49.59M
Cost of Revenue
$ 35.55M$ 28.64M$ 7.55M$ ―$ ―$ 13.32M
Gross Profit
$ 155.74M$ 135.27M$ 30.45M$ 33.20M$ 110.25M$ 36.27M
Operating Expense
$ 231.53M$ 207.92M$ 46.43M$ 41.15M$ 169.55M$ 164.75M
Operating Income
$ -40.24M$ -44.01M$ -15.98M$ -7.96M$ -59.31M$ -115.16M
Net Non Operating Interest Income Expense
$ -8.35M$ -21.86M$ -5.30M$ -4.92M$ -12.75M$ -6.87M
Other Income Expense
$ -2.51M$ -2.36M$ -767.00K$ -1.36M$ 24.03M$ 702.00K
Pretax Income
$ -46.08M$ -63.50M$ -20.52M$ -16.83M$ -96.08M$ -122.72M
Tax Provision
$ -2.61M$ -1.25M$ -675.00K$ ―$ -1.42M$ -4.42M
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ -53.95M$ -62.26M$ -19.84M$ -16.83M$ -94.66M$ -122.72M
Basic EPS
$ ―$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―$ ―
Basic Average Shares
$ ―$ ―$ ―$ ―$ ―$ ―
Diluted Average Shares
$ ―$ ―$ ―$ ―$ ―$ ―
Dividend Per Share
$ ―$ ―$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―$ ―$ ―
Total Expenses
$ 267.08M$ 236.57M$ 53.99M$ 41.15M$ 169.55M$ 178.06M
Net Income From Continuing And Discontinued Operation
$ -61.91M$ -62.26M$ -19.84M$ -16.83M$ -94.66M$ -122.72M
Normalized Income
$ -41.04M$ -69.95M$ -21.97M$ ―$ ―$ ―
Interest Expense
$ ―$ ―$ ―$ ―$ ―$ ―
EBIT
$ -47.95M$ -36.90M$ -13.99M$ -11.92M$ -80.76M$ -119.97M
EBITDA
$ -32.90M$ -22.79M$ -7.15M$ -9.21M$ -66.35M$ -116.71M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis